Hatice Evren EKER, Oya YALÇIN ÇOK, Aniş ARIBOĞAN

Ketamine dosing for sedation during repeated radiotherapy sessions in children

Background/aim: We report the analysis of ketamine doses needed and the recovery times in pediatric oncology patients undergoingrepeated radiotherapy sessions.Materials and methods: In a single-blind prospective study design, thirty-three pediatric patients undergoing radiotherapy due tooncologic disorders received 2 mg/kg ketamine and 10 µg/kg atropine intravenously and the rescue drug to be administered wasketamine at 0.5 mg/kg when the sedation level was inadequate. Total ketamine consumption, additional doses, and recovery time wererecorded.Results: Data of 635 consecutive radiotherapy sessions were evaluated. There was no significant alteration in total ketamine consumptionrequired to complete the radiotherapy periods during consecutive procedures (P > 0.05). However, the recovery times started to decreaseby the fourth session (P = 0.02) and continued to decrease onwards during the whole study period (P = 0.001). The mean of the firstrecovery time was 13.68 ± 3.99 min, whereas the mean of the last recovery time was 7.66 ± 6.35 min.Conclusion: A requirement for an incremental increase in ketamine dose after subsequent administrations was not detected, despitea significant decrease in recovery times being anticipated when ketamine is used repeatedly for sedative purposes in consecutiveradiotherapy sessions.

PDF

___

Lois F, De Kock M. Something new about ketamine for pediatric anesthesia? Curr Opin Anaesthesiol 2008; 21: 340- 344.
Soyannwo OA, Amanor-Boadu SD, Adenipekun A, Sanusi AA, Akinyemi OA. Ketamine anaesthesia for young children undergoing radiotherapy. West Afr J Med 2001; 20: 136-139.
Trujillo KA, Zamora JJ, Warmoth KP. Increased response to ketamine following treatment at long intervals: implications for intermittent use. Biol Psychiatry 2008; 63: 178-183.
Uchihashi Y, Kuribara H, Morita T, Fujita T. The repeated administration of ketamine induces an enhancement of its stimulant action in mice. Jpn J Pharmacol 1993; 61: 149-151.
Khan MS, Bhatti AH. Ketamine tolerance. Postgrad Med J 1988; 64: 833-834.
Trujillo KA, Akil H. Inhibition of opiate tolerance by noncompetitive N-methyl-D-aspartate receptor antagonists. Brain Res 1997; 633: 178-188.
Trujillo KA. The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity. Neurotox Res 2002; 4: 373-391.
Hoffman GM, Nowakowski R, Troshynski TJ, Berens RJ, Weisman SJ. Risk reduction in pediatric procedural sedation by application of an American Academy of Pediatrics/American Society of Anesthesiologists process model. Pediatrics 2002; 109: 236-243.
Watanabe Nemoto M, Nozaki-Taguchi N, Togasaki G, Kanazawa A, Kurokawa M, Harada R, Kobayashi H, Isono S, Uno T. New approach to relieving pain and distress during high-dose-rate intracavitary irradiation for cervical cancer. Brachytherapy 2015; 14: 642-647.
Zapantis A, Leung S. Tolerance and withdrawal issues with sedation. Crit Care Nurs Clin North Am 2005; 17: 211-223.
Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 2000; 28: 2122- 2132.
Herd DW, Anderson BJ, Keene NA, Holford NHG. Investigating the pharmacodynamics of ketamine in children. Paediatr Anaesth 2008; 18: 36-42.
Tozer GM, Penhaligon M, Nias AH. The use of ketamine plus diazepam anaesthesia to increase the radiosensitivity of a C3H mouse mammary adenocarcinoma in hyperbaric oxygen. Br J Radiol 1984; 57: 75-80.
Pouget P, Wattiez N, Rivaud-Péchoux S, Gaymard B. Rapid development of tolerance to sub-anaesthetic dose of ketamine: an oculomotor study in macaque monkeys. Psychopharmacology 2010; 209: 313-318. 15. Livingston A, Waterman AE. The development of tolerance to ketamine in rats and the significance of hepatic metabolism. Br J Pharmacol 1978; 64: 63-69.